Tracking every rollback, reversal, and overreach — and the path back to the America we know.
Health Secretary Robert F. Kennedy Jr. restructured the Advisory Committee on Immunization Practices (ACIP), a key federal vaccine policy body. Senate Democrats launched an investigation into the legal and public health consequences of the panel changes. The action affects vaccine approval processes and guidance affecting millions of Americans.
President Trump signed Executive Order 14297 to implement Most-Favored-Nation (MFN) pricing for prescription drugs, requiring Medicare to pay no more than the lowest price paid in other developed nations. The order aims to reduce drug costs for American patients and Medicare spending by allowing the government to negotiate lower pharmaceutical prices based on international benchmarks.
Executive Order 14293 signed on May 5, 2025, removes regulatory barriers to increase domestic production of critical medicines in the United States. The order streamlines FDA approval processes and reduces compliance requirements for pharmaceutical manufacturers. This aims to reduce American dependence on foreign drug sources and lower medication costs for consumers.
The Trump administration ousted FDA acting drug chief Dr. Tracy Beth Høeg, acting vaccines chief Katherine Szarama, and chief of staff Jim Traficant in a major leadership shake-up. The agency now lacks a permanent commissioner and stable leadership during critical drug approval and vaccine oversight functions. The departure of experienced regulators weakens FDA capacity to evaluate drug safety and vaccine efficacy during a period of potential regulatory rollback.
The Trump administration's budget law mandates work requirements for Medicaid beneficiaries, with Nebraska implementing the policy on May 1 and most states required to follow by January. The requirement forces many low-income Americans to prove employment to maintain health coverage, directly affecting millions of vulnerable populations who may struggle to meet work documentation standards.
President Trump signed Executive Order 14273 on April 15, 2025, implementing measures aimed at lowering prescription drug prices for American consumers. The order directs federal agencies to reduce pharmaceutical costs through regulatory reform and market mechanisms. This action is intended to decrease out-of-pocket medication expenses for Medicare, Medicaid, and privately insured Americans.
The Department of Health and Human Services withdrew its proposed amendment to the charter of a key vaccine advisory committee that would have loosened eligibility requirements for panel members. The withdrawal, citing administrative errors, halts efforts to restructure the influential committee's membership criteria. The action affects the composition and independence of the advisory body that shapes national vaccination policy.
The Trump administration eliminated over $800 million in federal grants from the Department of Justice's Office of Justice Programs designated for community violence intervention initiatives in April 2025. These programs have proven more effective at reducing homicides than arrest-focused approaches. The cuts risk reversing recent dramatic declines in US homicide rates and disproportionately harm communities already experiencing high rates of violent crime.
Defense Secretary Pete Hegseth eliminated mandatory influenza vaccination requirements for active-duty service members. The policy change resulted in over 160 troops contracting flu at Lackland Air Force Base in Texas within weeks. The action removes public health protections across the military while increasing disease transmission among personnel in close quarters.
The Trump administration prohibited federal funding for fentanyl test strips while simultaneously supporting naloxone access, creating contradictory overdose prevention policies. Experts say the restriction on test strips—which help people identify dangerous drugs and avoid overdoses—strains health resources and increases overdose risk. The conflicting approaches undermine harm reduction efforts nationwide.